DERMA SCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
11 Enero 2017 - 10:05AM
Business Wire
Rigrodsky & Long, P.A.:
- Do you own shares of Derma Sciences,
Inc. (NASDAQ CM: DSCI)?
- Did you purchase any of your shares
prior to January 11, 2017?
- Do you think the proposed buyout
price is too low?
- Do you want to discuss your
rights?
Rigrodsky & Long, P.A. announces that it is investigating
potential legal claims against the board of directors of Derma
Sciences, Inc. (“Derma Sciences” or the “Company”) (NASDAQ CM:
DSCI) regarding possible breaches of fiduciary duties and other
violations of law related to the Company’s entry into an agreement
to be acquired by Integra LifeSciences Holdings Corporation
(“Integra”) (NASDAQ GS: IART).
Click here to learn more:
http://rigrodskylong.com/investigations/derma-sciences-inc-dsci-buyout.
Under the terms of the agreement, shareholders of Derma Sciences
will receive $7.00 in cash for each share of Derma Sciences common
stock.
The investigation concerns whether Derma Sciences’ board of
directors failed to adequately shop the Company and obtain the best
possible value for Derma Sciences shareholders before entering into
an agreement with Integra.
If you own the common stock of Derma Sciences and purchased your
shares before January 11, 2017, if you have information or would
like to learn more about these claims, or if you wish to discuss
these matters or have any questions concerning this announcement or
your rights or interests with respect to these matters, please
contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long,
P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by
telephone at (888) 969-4242; by e-mail to info@rl-legal.com, or at:
http://rigrodskylong.com/investigations/derma-sciences-inc-dsci-buyout.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware
and Garden City, New York, regularly prosecutes securities class,
derivative and direct actions, shareholder rights litigation and
corporate governance litigation, on behalf of shareholders in
states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar
outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170111005806/en/
Rigrodsky & Long, P.A.Seth D. RigrodskyGina M.
Serra888-969-4242302-295-5310Fax:
302-654-7530info@rl-legal.comhttp://www.rigrodskylong.com
Derma Sciences, Inc. (NASDAQ:DSCI)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Derma Sciences, Inc. (NASDAQ:DSCI)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024